During the last session, Agilon Health Inc (NYSE:AGL)’s traded shares were 5.58 million, with the beta value of the company hitting 0.67. At the end of the trading day, the stock’s price was $3.57, reflecting an intraday gain of 4.08% or $0.14. The 52-week high for the AGL share is $7.73, that puts it down -116.53 from that peak though still a striking 57.98% gain since the share price plummeted to a 52-week low of $1.50. The company’s market capitalization is $1.47B, and the average intraday trading volume over the past 10 days was 4.18 million shares, and the average trade volume was 4.21 million shares over the past three months.
Agilon Health Inc (AGL) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.86. AGL has a Sell rating from 0 analyst(s) out of 10 analysts who have looked at this stock. 3 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 7 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.13.
Agilon Health Inc (NYSE:AGL) trade information
Agilon Health Inc (AGL) registered a 4.08% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 4.08% in intraday trading to $3.57, hitting a weekly high. The stock’s 5-day price performance is 2.00%, and it has moved by 23.96% in 30 days. Based on these gigs, the overall price performance for the year is -47.65%. The short interest in Agilon Health Inc (NYSE:AGL) is 20.24 million shares and it means that shorts have 3.77 day(s) to cover.
The consensus price target of analysts on Wall Street is $2.75, which implies a decrease of -29.82% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $2.5 and $3 respectively. As a result, AGL is trading at a premium of 15.97% off the target high and 29.97% off the low.
Agilon Health Inc (AGL) estimates and forecasts
In the rating firms’ projections, revenue will increase 40.30% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 1.52B as predicted by 19 analyst(s). Meanwhile, a consensus of 13 analyst(s) estimates revenue growth to 1.7B by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 1.06B and 1.6B respectively. In this case, analysts expect current quarter sales to grow by 43.84% and then jump by 5.87% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 7.65%. While earnings are projected to return -15.75% in 2025, the next five years will return 24.06% per annum.
AGL Dividends
Agilon Health Inc is due to release its next quarterly earnings in March. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 56.93 million shares, is of FMR LLC’s that is approximately 13.8418% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $372.3 million.
Also, the Mutual Funds coming in first place with the largest holdings of Agilon Health Inc (AGL) shares are Vanguard Specialized-Health Care Fund and Smallcap World Fund . Data provided on Oct 31, 2024 indicates that Vanguard Specialized-Health Care Fund owns about 38.68 shares. This amounts to just over 9.39 percent of the company’s overall shares, with a $138.09 million market value. The same data shows that the other fund manager holds slightly less at 23.57, or about 5.72% of the stock, which is worth about $84.15 million.
